Log In
BCIQ
Print this Print this
 

Axumin, [18F]-fluciclovine

Also known as: FACBC, Fluciclovine

  Manage Alerts
Collapse Summary General Information
Company General Electric Co.
DescriptionSynthetic amino acid-based PET radiopharmaceutical
Molecular Target
Mechanism of ActionImaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect recurrent prostate cancer; Diagnose glioma; Lesion detection and localisation for patients with recurrent prostate cancer
Regulatory Designation U.S. - Orphan Drug (Diagnose glioma);
U.S. - Priority Review (Lesion detection and localisation for patients with recurrent prostate cancer);
EU - Orphan Drug (Diagnose glioma)
PartnerBlue Earth Diagnostics Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today